Adaptive statistical analysis following sample size modification based on interim review of effect size

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 4, 2005, Pages 693-706

  Hung, H M James ^a   Cui, Lu ^b   Wang, Sue Jane ^a   Lawrence, John ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b SANOFI   (France)

Author keywords

Adaptive test; Confidence interval; Estimation; Group sequential trial; Non sequential trial; Power; Type I error

Indexed keywords

ADAPTIVE DESIGN; CLINICAL TRIAL; CONFIDENCE INTERVAL; GROUP SEQUENTIAL TRIAL; METHODOLOGY; NON SEQUENTIAL TRIAL; PRIORITY JOURNAL; PROBABILITY; REVIEW; SAMPLE SIZE; SAMPLING; SEQUENTIAL ANALYSIS; STATISTICAL ANALYSIS;

ALGORITHMS; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 22044449167     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-200062855     Document Type: Review

References (37)

1. Bauer, P., Köhne, K. (1994). Evaluations of experiments with adaptive interim analyses. Biometrics 50:1029-1041.
2. Bauer, P., Röhmel, J. (1995). An adaptive method for establishing a dose response relationship. Statist. Med. 14:1595-1607.
3. Bauer, P., Brannath, W., Posch, M. (2001). Flexible two-stage designs: An overview. Meth. Info. Med. 40:117-121.
4. Berry, D. A. (2002). Adaptive trials and Bayesian statistics in drug development. Biopharmaceutical Report 9:1-7.
5. Brannath, W., Posch, M., Bauer, P. (2002). Recursive combination tests. J. Amer. Statist. Assoc. 97:236-244.
6. Chen, Y. H. J., DeMets, D. L., Lan, K. K. G. (2004). Increasing the sample size when the unblended interim result is promising. Statist. Med. 23:1023-1038.
7. Cui, L. (1999). Adaptive testing with multiple sample size adjustments. Proc. Biopharmaceutical Sec. Amer. Statist. Assoc. 101-105.
8. Cui, L. (2002). Sample size re-estimation based on observed treatment difference. In Chow, S. C., ed. Encyclopedia of Biopharmaceutical Statistics. 2nd ed. New York: Marcel Dekker, pp. 915-919.
9. Cui, L., Hung, H. M. J., Wang, S. J. (1997). Impact of changing sample size in a group sequential clinical trial. Proc. Biopharmaceutical Sec. Amer. Statist. Assoc. 52-57.
10. Cui, L., Hung, H. M. J., Wang, S. J. (1999). Modification of sample size in group sequential clinical trials. Biometrics 55:321-324.
11. Fisher, L. D. (1998). Self-designing clinical trials. Statist. Med. 17:1551-1562.
12. Gould, A. L., Shih, W. J. (1992). Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Comm. Statist. Theo. Meth. 21:2833-2853.
13. Gould, A. L., Shih, W. J. (1998). Modifying the design of ongoing trials without unblinding. Statist. Med. 17:89-100.
14. Jennison, C., Turnbull, B. W. (1999). Group Sequential Methods with Applications to Clinical Trials. New York: Chapman and Hall/CRC Press.
15. Jennison, C., Turnbull, B. W. (2003). Mid-course sample size modification in clinical trials. Statist. Med. 22:971-993.
16. Keiser, M., Bauer, P., Lehmacher, W. (1999). Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical J. 41:261-277.
17. Lehmacher, W., Wassmer, G. (1999). Adaptive sample size calculation in group sequential trials. Biometrics 55:1286-1290.
18. Lan, K. K. G., DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika 70:659-663.
19. Lan, K. K. G., Trost, D. C. (1997). Estimation of parameters and sample size re-estimation. Proc. Biopharmaceutical Sec. Amer. Statist. Assoc. 48-51.
20. Lan, K. K. G., Soo, Y., Siu, C., Wang, M. (2005). The use of weighted Z-tests in medical research. J. Biopharmaceutical Statist. 15:625-639.
21. Lawrence, J. (2002). Design of clinical trials using an adaptive test statistic. Pharm. Statist. 1:97-105.
22. Lawrence, J., Hung, H. M. J. (2003). Estimation and confidence intervals after adjusting the maximum information. Biometrical J. 45:143-152.
23. Li, G., Shih, W. J., Xie, T., Lu, J. (2002). A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics 3:277-287.
24. Liu, Q., Chi, G. (2001). On sample size and inference for two-stage adaptive designs. Biometrics 57:172-177.
25. Liu, Q., Proschan, M. A., Pledger, G. W. (2002). A unified theory of two-stage adaptive designs. J. Amer. Statist. Assoc. 97:1034-1041.
26. Müller, H., Schäfer, H. (2001). Adaptive group sequential designs in clinical trials: Combining the advantages of adaptive and of classical group sequential approaches. Biometrics 37:886-891.
27. Posch, M., Bauer, P. (1999). Adaptive two stage designs and the conditional error function. Biometrical J. 41:689-696.
28. Proschan, M. A., Hunsberger, S. A. (1995). Designed extension of studies based on conditional power. Biometrics 51:1315-1324.
29. Proschan, M. A., Liu, Q., Hunsberger, S. A. (2003). Practical midcourse sample size modiction in clinical trials. Controlled Clin. Trials 24:4-15.
30. Robussin, D. M., DeMets, D. L., Kim, K., Lan, K. K. G. (2001). Computations for group sequential boundaries using the Lan-DeMets spending method. Controlled Clin. Trials 21:190-207.
31. Shen, Y., Fisher. L. D. (1999). Statistical inference for self-designing clinical trials with a one-sided hypothesis. Biometrics 55:190-197.
32. Shih, W. J. (1992). Sample size re-estimation in clinical trials. In Peace, K., ed. Biopharmaceutical Sequential Statistical Applications. New York: Marcel Dekker, pp. 285-301.
33. Shih, W. J. (2001). Sample size re-estimation-journey for a decade. Statist. Med. 20:515-518.
34. Shun, Z., Yuan, W., Brady, W., Hsu, H. (2001). Type I error in sample size re-estimation based on observed treatment difference. Statist. Med. 20:497-513.
35. Tsiatis, A. A., Mehta, C. R. (2003). On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 90:367-378.
36. Wang, S. J., Hung, H. M. J., Tsong, Y., Cui, L. (2001). Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials. Statist. Med. 20:1903-1912.
37. Wittes, J., Brittain, E. (1990). The role of internal pilot studies in increasing the efficiency of clinical trials. Statist. Med. 9:65-72.